Quick Answer
OptimizeRx Corp reported Total Revenue of $109.43 million for fiscal year 2025.
OptimizeRx Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $109.43M | +18.8% |
| 2024 | $92.13M | +28.8% |
| 2023 | $71.52M | +14.5% |
| 2022 | $62.45M | +1.9% |
| 2021 | $61.29M | +41.5% |
| 2020 | $43.31M | +76.1% |
| 2019 | $24.60M | +16.0% |
| 2018 | $21.21M | +74.9% |
| 2017 | $12.13M | +56.5% |
| 2016 | $7.75M | +7.4% |
| 2015 | $7.22M | +11.0% |
| 2014 | $6.50M | +39.0% |
| 2013 | $4.68M | +135.3% |
| 2012 | $1.99M | +79.0% |
| 2011 | $1.11M | +1464.1% |
| 2010 | $71.1K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.07M | +22.3% | -10.7% |
| June 30, 2025 | $29.20M | +55.2% | +33.1% |
| March 31, 2025 | $21.93M | +11.4% | +2.9% |
| September 30, 2024 | $21.31M | +30.5% | +13.3% |
| June 30, 2024 | $18.81M | +36.1% | -4.5% |
| March 31, 2024 | $19.69M | +51.4% | +20.6% |
| September 30, 2023 | $16.33M | +8.3% | +18.2% |
| June 30, 2023 | $13.82M | -1.1% | +6.3% |
- OptimizeRx Corp showed an increase of +18.8% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2025 period, OptimizeRx Corp’s total revenue has grown by 153884.4% (from $71.1 thousand to $109.43 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: